Portola Pharma (PTLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2017 | 06-2017 | 03-2017 | 12-2016 | 09-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 344,191 | 124,009 | 135,843 | 188,658 | 100,591 |
| Marketable Securities | 225,107 | 145,861 | 182,528 | 130,291 | 175,936 |
| Receivables | N/A | N/A | N/A | N/A | 5,000 |
| Other current assets | 1,888 | 3,487 | 5,898 | 7,299 | 15,575 |
| TOTAL | $579,952 | $285,687 | $327,581 | $328,928 | $301,698 |
| Non-Current Assets | |||||
| PPE Net | 5,614 | 5,576 | 5,795 | 6,143 | 6,384 |
| Investments And Advances | 28,625 | 0 | 0 | 0 | 0 |
| Intangibles | 7,996 | 8,151 | 3,151 | 3,151 | 3,151 |
| Other Non-Current Assets | 9,609 | 6,277 | 4,168 | 5,214 | 6,316 |
| TOTAL | $51,844 | $20,004 | $13,114 | $14,508 | $15,851 |
| Total Assets | $631,796 | $305,691 | $340,695 | $343,436 | $317,549 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 17,463 | 11,938 | 9,487 | 14,546 | 8,993 |
| Accrued Expenses | 28,209 | 25,088 | 14,452 | 25,514 | 17,772 |
| TOTAL | $69,769 | $57,773 | $48,136 | $65,664 | $47,430 |
| Non-Current Liabilities | |||||
| Long Term Debt | 104,893 | 101,744 | 98,288 | 49,815 | N/A |
| Deferred Revenues | 15,187 | 15,187 | 20,798 | 20,798 | 17,148 |
| Other Non-Current Liabilities | 10,917 | 10,906 | 10,752 | 11,226 | 408 |
| TOTAL | $133,638 | $134,551 | $128,832 | $85,083 | $28,818 |
| Total Liabilities | $203,407 | $192,324 | $176,968 | $150,747 | $76,248 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 65,252 | 57,663 | 57,020 | 56,557 | 56,544 |
| Common Shares | 67 | 59 | 58 | 57 | 57 |
| Retained earnings | -1,112,571 | -1,029,634 | -959,980 | -918,345 | -864,504 |
| Other shareholders' equity | 2,310 | 2,282 | 2,021 | 2,145 | 4,824 |
| TOTAL | $428,389 | $113,367 | $163,727 | $192,689 | $241,301 |
| Total Liabilities And Equity | $631,796 | $305,691 | $340,695 | $343,436 | $317,549 |